FDA Clearance Tracker · P960058-S043
HIRESOLUTION BIONIC EAR SYSTEM
Last checked: Nov 20, 2026Latest source record: Dec 23, 2005 (this decision)Source: openFDAMethods & limitations
Decided
Dec 23, 2005
Approved
Time to decision
171 days
Received Jul 5, 2005. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P960058-S043
- Device name
- HIRESOLUTION BIONIC EAR SYSTEM
- Applicant
- Advanced Bionics
- Applicant location
- Valencia, CA
- Received
- Jul 5, 2005
- Decided
- Dec 23, 2005
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P960058
Device type
- Device type
- Implant, cochlear (MCM)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
APPROVAL FOR PROCESS CONTROL IMPROVEMENTS TO THE HIRES90K COIL-CASE/ELECTRODE SUBASSEMBLY FINAL MOLDING PROCESS. THE PROPOSED CHANGES INCLUDE AN EXTERNAL THERMOCOUPLE TO PROVIDE CLOSED-LOOP CONTROL OF THE MOLD TEMPERATURE, THEREBY PROVIDING BETTER CONTROL OF THE CURING TEMPERATURE OF THE SILICONE, AND BY CONFIGURING THE MOLD TOOL WITH SPRING WASHER (BELLEVILLE WASHERS) TO ALLOW FOR SMOOTHER MOVEMENT. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME HIRESOLUTION BIONIC EAR SYSTEM AND IS INDICATED FOR INDIVIDUALS AGED 12 MONTHS AND OLDER WITH SEVERE-TO-PROFOUND SENSORINEURAL HEARING LOSS TO RESTORE A LEVEL OF AUDITORY SENSATION VIA ELECTRICAL STIMULATION OF THE AUDITORY NERVE.
Source documents
Other decisions for Advanced Bionics
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- HiResolution Bionic Ear SystemPMA supplement
P960058-S167 · Decided Jul 22, 2026 · 539 days after receipt · Panel Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.